Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Rolls Out Second ‘Biosimilars Week’

Health Minister Greg Hunt Kicks Off Week-Long Education Event

Executive Summary

A series of educational events and messages are being rolled out by Australia’s GBMA industry association as part of “Biosimilar Awareness Week.”

You may also be interested in...



Australian Body Welcomes Passage Of Shortages Law

Legislation setting out measures to mitigate shortages in Australia has been passed by the country’s senate, incorporating into law key provisions of new five-year pact between the off-patent industry and the government.

Australia Extends Biosimilar Education Efforts

Australia’s government has agreed to extend a successful biosimilar education initiative led by the local GBMA industry association.

Australian Confidence In Biosimilar Switching ‘More Than Doubled Since 2016’

A new reported commissioned by Australia’s Generic and Biosimilar Medicines Association shows a ‘marked increase’ in confidence for biosimilars among a number of different stakeholders.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

GB149932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel